Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

COMPLICATION RATES IN PATIENTS WITH NEGATVE AXILLARY NODES 10-YEARS AFTER LOCAL BREAST RADIOTHERAPY FOLLOWING EITHER SENTINEL LYMPH NODE DISSECTION OR AXILLARY CLEARANCE

Identifieur interne : 003831 ( Main/Exploration ); précédent : 003830; suivant : 003832

COMPLICATION RATES IN PATIENTS WITH NEGATVE AXILLARY NODES 10-YEARS AFTER LOCAL BREAST RADIOTHERAPY FOLLOWING EITHER SENTINEL LYMPH NODE DISSECTION OR AXILLARY CLEARANCE

Auteurs : A. Gabriella Wernicke [États-Unis] ; Michael Shamis [États-Unis] ; Kulbir K. Sidhu [États-Unis] ; Bruce C. Turner [États-Unis] ; Yevgenyia Goltser [États-Unis] ; Imraan Khan [États-Unis] ; Paul J. Christos [États-Unis] ; Lydia T. Komarnicky-Kocher [États-Unis]

Source :

RBID : PMC:4064796

Descripteurs français

English descriptors

Abstract

Background

We assess complication rates in node negative breast cancer patients treated with breast radiotherapy (RT) only after sentinel lymph node dissection (SLND) or axillary lymph node dissection (ALND).

Materials and Methods

Between 1995 and 2001, 226 women with AJCC stage I-II breast cancer were treated with lumpectomy, either SLND or SLND+ALND, and had available toxicities in follow-up: 111/136 (82%) and 115/129 (89%) in SLND and ALND groups, respectively. RT targeted the breast to median dose of 48.2Gy (range, 46.0-50.4Gy) without axillary RT. Chi-square tests compared complication rates of two groups for axillary web syndrome (AWS), seroma, wound infection, decreased range of motion (ROM) of the ipsilateral shoulder, paresthesia, and lymphedema.

Results

Median follow-up was 9.9 years (range, 8.3 -15.3 years). Median number of nodes assessed was 2 (range, 1-5) in SLND and 18 (range, 7-36) in ALND (p<0.0001). Acute complications occurred during the first 2 years and were AWS, seroma, and wound infection. Incidences of seroma 5/111 (4.5%) in SLND and 16/115 (13.9%) in ALND (p<0.02, respectively) and wound infection 3/111 (2.7%) in SLND and 10/115 (8.7%) in ALND (p<0.05, respectively) differed significantly. AWS was not statistically different between the groups. At 10-years, the only chronic complications were decreased ROM of the shoulder 46/111 (41.4%) in SLND and 92/115 (80.0%) in ALND (p<0.0001), paresthesia 12/111 (10.8%) in SLND and 39/115 (33.9%) in ALND (p<0.0001), and lymphedema assessed by patients 10/111 (10.0%) in SLND and 39/115 (33.9%) in ALND (p<0.0001). Chronic lymphedema, assessed by clinicians, occurred in 6/111 (5.4%) in SLND and 21/115 (18.3%) in ALND cohorts, respectively (p<0.0001).

Conclusion

Our mature findings support that in patients with negative axillary nodal status SLND and breast RT provide excellent long-term cure rates while avoiding morbidities associated with ALND or addition of axillary RT field.


Url:
DOI: 10.1097/COC.0b013e3182354bda
PubMed: 22134519
PubMed Central: 4064796


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">COMPLICATION RATES IN PATIENTS WITH NEGATVE AXILLARY NODES 10-YEARS AFTER LOCAL BREAST RADIOTHERAPY FOLLOWING EITHER SENTINEL LYMPH NODE DISSECTION OR AXILLARY CLEARANCE</title>
<author>
<name sortKey="Wernicke, A Gabriella" sort="Wernicke, A Gabriella" uniqKey="Wernicke A" first="A. Gabriella" last="Wernicke">A. Gabriella Wernicke</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Radiation Oncology, Weill Medical College of Cornell University, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Radiation Oncology, Weill Medical College of Cornell University, New York</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Shamis, Michael" sort="Shamis, Michael" uniqKey="Shamis M" first="Michael" last="Shamis">Michael Shamis</name>
<affiliation wicri:level="2">
<nlm:aff id="A2">Department of Medical Sciences, Saint George University, Grenada, WI</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Wisconsin</region>
</placeName>
<wicri:cityArea>Department of Medical Sciences, Saint George University, Grenada</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="K Sidhu, Kulbir" sort="K Sidhu, Kulbir" uniqKey="K Sidhu K" first="Kulbir" last="K. Sidhu">Kulbir K. Sidhu</name>
<affiliation wicri:level="2">
<nlm:aff id="A3">Department of Radiation Oncology, Thomas Jefferson University Hospital, Philadelphia, PA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Department of Radiation Oncology, Thomas Jefferson University Hospital, Philadelphia</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Turner, Bruce C" sort="Turner, Bruce C" uniqKey="Turner B" first="Bruce C." last="Turner">Bruce C. Turner</name>
<affiliation wicri:level="2">
<nlm:aff id="A3">Department of Radiation Oncology, Thomas Jefferson University Hospital, Philadelphia, PA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Department of Radiation Oncology, Thomas Jefferson University Hospital, Philadelphia</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Goltser, Yevgenyia" sort="Goltser, Yevgenyia" uniqKey="Goltser Y" first="Yevgenyia" last="Goltser">Yevgenyia Goltser</name>
<affiliation wicri:level="2">
<nlm:aff id="A4">Department of Biological Sciences, Brandeis University, Waltham, MA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Biological Sciences, Brandeis University, Waltham</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Khan, Imraan" sort="Khan, Imraan" uniqKey="Khan I" first="Imraan" last="Khan">Imraan Khan</name>
<affiliation wicri:level="2">
<nlm:aff id="A5">Department of Biological Sciences, State University of New York, Stony Brook, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Biological Sciences, State University of New York, Stony Brook</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Christos, Paul J" sort="Christos, Paul J" uniqKey="Christos P" first="Paul J." last="Christos">Paul J. Christos</name>
<affiliation wicri:level="2">
<nlm:aff id="A6">Division of Biostatistics and Epidemiology, Department of Public Health, Weill Cornell Medical College of Cornell University, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Division of Biostatistics and Epidemiology, Department of Public Health, Weill Cornell Medical College of Cornell University, New York</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Komarnicky Kocher, Lydia T" sort="Komarnicky Kocher, Lydia T" uniqKey="Komarnicky Kocher L" first="Lydia T." last="Komarnicky-Kocher">Lydia T. Komarnicky-Kocher</name>
<affiliation wicri:level="2">
<nlm:aff id="A7">Department of Radiation Oncology, Drexel University Hospital, Philadelphia, PA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Department of Radiation Oncology, Drexel University Hospital, Philadelphia</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">22134519</idno>
<idno type="pmc">4064796</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064796</idno>
<idno type="RBID">PMC:4064796</idno>
<idno type="doi">10.1097/COC.0b013e3182354bda</idno>
<date when="2013">2013</date>
<idno type="wicri:Area/Pmc/Corpus">003771</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003771</idno>
<idno type="wicri:Area/Pmc/Curation">003770</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">003770</idno>
<idno type="wicri:Area/Pmc/Checkpoint">002463</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">002463</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="wicri:Area/PubMed/Corpus">002363</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002363</idno>
<idno type="wicri:Area/PubMed/Curation">002363</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002363</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002363</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002363</idno>
<idno type="wicri:Area/Ncbi/Merge">004870</idno>
<idno type="wicri:Area/Ncbi/Curation">004870</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004870</idno>
<idno type="wicri:doubleKey">0277-3732:2013:Wernicke A:complication:rates:in</idno>
<idno type="wicri:Area/Main/Merge">003839</idno>
<idno type="wicri:Area/Main/Curation">003831</idno>
<idno type="wicri:Area/Main/Exploration">003831</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">COMPLICATION RATES IN PATIENTS WITH NEGATVE AXILLARY NODES 10-YEARS AFTER LOCAL BREAST RADIOTHERAPY FOLLOWING EITHER SENTINEL LYMPH NODE DISSECTION OR AXILLARY CLEARANCE</title>
<author>
<name sortKey="Wernicke, A Gabriella" sort="Wernicke, A Gabriella" uniqKey="Wernicke A" first="A. Gabriella" last="Wernicke">A. Gabriella Wernicke</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Radiation Oncology, Weill Medical College of Cornell University, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Radiation Oncology, Weill Medical College of Cornell University, New York</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Shamis, Michael" sort="Shamis, Michael" uniqKey="Shamis M" first="Michael" last="Shamis">Michael Shamis</name>
<affiliation wicri:level="2">
<nlm:aff id="A2">Department of Medical Sciences, Saint George University, Grenada, WI</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Wisconsin</region>
</placeName>
<wicri:cityArea>Department of Medical Sciences, Saint George University, Grenada</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="K Sidhu, Kulbir" sort="K Sidhu, Kulbir" uniqKey="K Sidhu K" first="Kulbir" last="K. Sidhu">Kulbir K. Sidhu</name>
<affiliation wicri:level="2">
<nlm:aff id="A3">Department of Radiation Oncology, Thomas Jefferson University Hospital, Philadelphia, PA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Department of Radiation Oncology, Thomas Jefferson University Hospital, Philadelphia</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Turner, Bruce C" sort="Turner, Bruce C" uniqKey="Turner B" first="Bruce C." last="Turner">Bruce C. Turner</name>
<affiliation wicri:level="2">
<nlm:aff id="A3">Department of Radiation Oncology, Thomas Jefferson University Hospital, Philadelphia, PA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Department of Radiation Oncology, Thomas Jefferson University Hospital, Philadelphia</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Goltser, Yevgenyia" sort="Goltser, Yevgenyia" uniqKey="Goltser Y" first="Yevgenyia" last="Goltser">Yevgenyia Goltser</name>
<affiliation wicri:level="2">
<nlm:aff id="A4">Department of Biological Sciences, Brandeis University, Waltham, MA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Biological Sciences, Brandeis University, Waltham</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Khan, Imraan" sort="Khan, Imraan" uniqKey="Khan I" first="Imraan" last="Khan">Imraan Khan</name>
<affiliation wicri:level="2">
<nlm:aff id="A5">Department of Biological Sciences, State University of New York, Stony Brook, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Biological Sciences, State University of New York, Stony Brook</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Christos, Paul J" sort="Christos, Paul J" uniqKey="Christos P" first="Paul J." last="Christos">Paul J. Christos</name>
<affiliation wicri:level="2">
<nlm:aff id="A6">Division of Biostatistics and Epidemiology, Department of Public Health, Weill Cornell Medical College of Cornell University, New York, NY</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Division of Biostatistics and Epidemiology, Department of Public Health, Weill Cornell Medical College of Cornell University, New York</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Komarnicky Kocher, Lydia T" sort="Komarnicky Kocher, Lydia T" uniqKey="Komarnicky Kocher L" first="Lydia T." last="Komarnicky-Kocher">Lydia T. Komarnicky-Kocher</name>
<affiliation wicri:level="2">
<nlm:aff id="A7">Department of Radiation Oncology, Drexel University Hospital, Philadelphia, PA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Department of Radiation Oncology, Drexel University Hospital, Philadelphia</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">American journal of clinical oncology</title>
<idno type="ISSN">0277-3732</idno>
<idno type="eISSN">1537-453X</idno>
<imprint>
<date when="2013">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Axilla (surgery)</term>
<term>Breast Neoplasms (radiotherapy)</term>
<term>Breast Neoplasms (surgery)</term>
<term>Female</term>
<term>Humans</term>
<term>Incidence</term>
<term>Lymph Node Excision (adverse effects)</term>
<term>Middle Aged</term>
<term>Postoperative Complications (epidemiology)</term>
<term>Postoperative Complications (etiology)</term>
<term>Retrospective Studies</term>
<term>Sentinel Lymph Node Biopsy (adverse effects)</term>
<term>Time Factors</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Aisselle ()</term>
<term>Biopsie de noeud lymphatique sentinelle (effets indésirables)</term>
<term>Complications postopératoires (épidémiologie)</term>
<term>Complications postopératoires (étiologie)</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Humains</term>
<term>Incidence</term>
<term>Jeune adulte</term>
<term>Lymphadénectomie (effets indésirables)</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Tumeurs du sein ()</term>
<term>Tumeurs du sein (radiothérapie)</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en">
<term>Lymph Node Excision</term>
<term>Sentinel Lymph Node Biopsy</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr">
<term>Biopsie de noeud lymphatique sentinelle</term>
<term>Lymphadénectomie</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Postoperative Complications</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Postoperative Complications</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en">
<term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr">
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en">
<term>Axilla</term>
<term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Complications postopératoires</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Complications postopératoires</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Female</term>
<term>Humans</term>
<term>Incidence</term>
<term>Middle Aged</term>
<term>Retrospective Studies</term>
<term>Time Factors</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Aisselle</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Humains</term>
<term>Incidence</term>
<term>Jeune adulte</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Tumeurs du sein</term>
<term>Études rétrospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<sec id="S1">
<title>Background</title>
<p id="P1">We assess complication rates in node negative breast cancer patients treated with breast radiotherapy (RT) only after sentinel lymph node dissection (SLND) or axillary lymph node dissection (ALND).</p>
</sec>
<sec id="S2">
<title>Materials and Methods</title>
<p id="P2">Between 1995 and 2001, 226 women with AJCC stage I-II breast cancer were treated with lumpectomy, either SLND or SLND+ALND, and had available toxicities in follow-up: 111/136 (82%) and 115/129 (89%) in SLND and ALND groups, respectively. RT targeted the breast to median dose of 48.2Gy (range, 46.0-50.4Gy) without axillary RT. Chi-square tests compared complication rates of two groups for axillary web syndrome (AWS), seroma, wound infection, decreased range of motion (ROM) of the ipsilateral shoulder, paresthesia, and lymphedema.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P3">Median follow-up was 9.9 years (range, 8.3 -15.3 years). Median number of nodes assessed was 2 (range, 1-5) in SLND and 18 (range, 7-36) in ALND (p<0.0001). Acute complications occurred during the first 2 years and were AWS, seroma, and wound infection. Incidences of seroma 5/111 (4.5%) in SLND and 16/115 (13.9%) in ALND (p<0.02, respectively) and wound infection 3/111 (2.7%) in SLND and 10/115 (8.7%) in ALND (p<0.05, respectively) differed significantly. AWS was not statistically different between the groups. At 10-years, the only chronic complications were decreased ROM of the shoulder 46/111 (41.4%) in SLND and 92/115 (80.0%) in ALND (p<0.0001), paresthesia 12/111 (10.8%) in SLND and 39/115 (33.9%) in ALND (p<0.0001), and lymphedema assessed by patients 10/111 (10.0%) in SLND and 39/115 (33.9%) in ALND (p<0.0001). Chronic lymphedema, assessed by clinicians, occurred in 6/111 (5.4%) in SLND and 21/115 (18.3%) in ALND cohorts, respectively (p<0.0001).</p>
</sec>
<sec id="S4">
<title>Conclusion</title>
<p id="P4">Our mature findings support that in patients with negative axillary nodal status SLND and breast RT provide excellent long-term cure rates while avoiding morbidities associated with ALND or addition of axillary RT field.</p>
</sec>
</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Massachusetts</li>
<li>Pennsylvanie</li>
<li>Wisconsin</li>
<li>État de New York</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="État de New York">
<name sortKey="Wernicke, A Gabriella" sort="Wernicke, A Gabriella" uniqKey="Wernicke A" first="A. Gabriella" last="Wernicke">A. Gabriella Wernicke</name>
</region>
<name sortKey="Christos, Paul J" sort="Christos, Paul J" uniqKey="Christos P" first="Paul J." last="Christos">Paul J. Christos</name>
<name sortKey="Goltser, Yevgenyia" sort="Goltser, Yevgenyia" uniqKey="Goltser Y" first="Yevgenyia" last="Goltser">Yevgenyia Goltser</name>
<name sortKey="K Sidhu, Kulbir" sort="K Sidhu, Kulbir" uniqKey="K Sidhu K" first="Kulbir" last="K. Sidhu">Kulbir K. Sidhu</name>
<name sortKey="Khan, Imraan" sort="Khan, Imraan" uniqKey="Khan I" first="Imraan" last="Khan">Imraan Khan</name>
<name sortKey="Komarnicky Kocher, Lydia T" sort="Komarnicky Kocher, Lydia T" uniqKey="Komarnicky Kocher L" first="Lydia T." last="Komarnicky-Kocher">Lydia T. Komarnicky-Kocher</name>
<name sortKey="Shamis, Michael" sort="Shamis, Michael" uniqKey="Shamis M" first="Michael" last="Shamis">Michael Shamis</name>
<name sortKey="Turner, Bruce C" sort="Turner, Bruce C" uniqKey="Turner B" first="Bruce C." last="Turner">Bruce C. Turner</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003831 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003831 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     PMC:4064796
   |texte=   COMPLICATION RATES IN PATIENTS WITH NEGATVE AXILLARY NODES 10-YEARS AFTER LOCAL BREAST RADIOTHERAPY FOLLOWING EITHER SENTINEL LYMPH NODE DISSECTION OR AXILLARY CLEARANCE
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:22134519" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024